Looksmaxxing drives $100M crypto peptide gray market

A Chainalysis report found on-chain payments to vendors selling peptides rose from roughly $12 million in the fourth quarter of 2025 to $32 million in the first quarter of 2026. The firm estimated flows of about $39 million in the second quarter of 2026 and said the market is on pace to exceed a $100 million annual run rate.

The firm linked the increase to growing online demand for appearance-enhancing products tied to a social-media trend called “looksmaxxing” and to continued interest in peptides marketed for weight loss. The report describes looksmaxxing as a movement focused on maximizing physical attractiveness through grooming, supplements, procedures and other interventions.

Peptides are short chains of amino acids used in some medical and cosmetic treatments and as the active ingredients in several weight-loss drugs. The report said lower-cost, unbranded peptide products are being sold directly to consumers by overseas suppliers.

Payments for these sales are routed mainly through Bitcoin and stablecoins, the report found, because banks and card processors often restrict transactions linked to unapproved pharmaceutical compounds. The firm noted a shift toward stablecoins for larger suppliers and wholesale orders and added, “When isolating vendors that average $1,000 or more per deposit, the asset mix shifts heavily toward majority stablecoins.”

Investigators identified China-based chemical manufacturers that moved into finished peptide sales after previously making precursor chemicals used in drugs such as fentanyl and amphetamines. The report named Shanghai Sigma Audley and Bigreat Technology as examples and said direct sales allow manufacturers to capture retail margins and reduce exposure compared with working through intermediaries.

Chainalysis estimated the on-chain peptide ecosystem now processes tens of millions of dollars in cryptocurrency each quarter. The firm did not respond to a request for comment.